The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
Brandes, Jan Lewis, Diener, Hans-Christoph, Dolezil, David, Freeman, Marshall C, McAllister, Peter J, Winner, Paul, Klatt, Jan, Cheng, Sunfa, Zhang, Feng, Wen, Shihua, Ritter, Shannon, Lenz, Robert A,Journal:
Cephalalgia
DOI:
10.1177/0333102419894559
Date:
December, 2019
File:
PDF, 838 KB
2019